Orthofix (OFIX) 10% Owner Juniper Investment Buys 310,000 Shares

What Happened
Juniper Investment Company, LLC — reported as a 10% owner / investment manager — acquired a total of 310,000 shares of Orthofix Medical, Inc. (OFIX) in two open‑market purchases. On 2026-09-18 it purchased 120,000 shares at a reported per‑share price of $8.74 (trade value $1,048,716; weighted‑average range noted as $8.65–$8.81 per F1). On 2026-09-21 it purchased 190,000 shares at $8.86 (trade value $1,683,381; weighted‑average range noted as $8.63–$8.98 per F2). Combined purchase value ≈ $2,732,097. These were outright purchases (acquisitions), which are generally viewed as accumulation rather than dispositions.

Key Details

• Transaction dates & prices:
  • 2026-09-18: 120,000 shares @ $8.74 (reported; F1 weighted‑avg range $8.65–$8.81) — $1,048,716
  • 2026-09-21: 190,000 shares @ $8.86 (reported; F2 weighted‑avg range $8.63–$8.98) — $1,683,381
• Total shares acquired: 310,000; total reported value ≈ $2.73M.
• Shares owned after the transactions: not stated in the provided filing excerpt.
• Filing: Form 4 filed 2026-09-22 covering trades on 9/18 and 9/21. The 9/21 trade was reported promptly; the 9/18 trade appears reported several business days later (see timeliness considerations).
• Notable footnotes:
  • F1/F2: weighted‑average price ranges provided; reporting person will supply trade details on request.
  • F3–F5: Juniper is the investment manager for several funds (e.g., Juniper Targeted Opportunity Fund, Juniper Multi‑Strategy, Juniper Targeted Opportunities) and may be deemed to beneficially own the securities held by those funds; Juniper and the named managing members disclaim beneficial ownership except to the extent of their pecuniary interest.

Context
This is institutional trading by an investment manager identified as a 10% owner rather than an individual executive. Such purchases by a manager or fund can indicate accumulation but do not reveal the manager’s full intent; beneficial ownership disclaimers mean Juniper may be reporting on behalf of funds it manages. No options, awards, gifts, or immediate dispositions were reported in this filing.